AlloMek Therapeutics - Ownership and Business Overview

Life ScienceCompany

AlloMek Therapeutics Ownership

Who owns AlloMek Therapeutics?

AlloMek Therapeutics is owned by Pasithea Therapeutics. It was acquired on October 12, 2022.

AlloMek Therapeutics Business Overview

Where is AlloMek Therapeutics headquartered?

AlloMek Therapeutics is headquartered in Woodbridge, Connecticut.

What sector is AlloMek Therapeutics in?

AlloMek Therapeutics is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 296 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 259 by strategics.

AlloMek Therapeutics

AlloMek Therapeutics LLC

4 Research Drive,
Woodbridge, Connecticut 06525
United States,
(203) 208-2811
www.allomek.com

AlloMek Therapeutics is a biotechnology company that provides CIP-137401, a potential macrocyclic mitogen-activated protein kinase kinase 1/2 (MEK) inhibitor for use in a range of CNS-related indications, including neurofibromatosis type 1 (NF1) and Noonan syndrome, as well as potential synergy with its existing multiple sclerosis (MS) development program. AlloMek Therapeutics is based in Woodbridge, Connecticut.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.